摘要
In patients with cirrhosis, anemia is common and is likely to be multifactorial, including decreased erythrocyte production,sequestration due to hypersplenism, hemolysis, and increased blood loss from gastrointestinal bleeding. Renal dysfunction is also common in liver disease and this may also cause anemia.However, an association between anemia and renal dysfunction has not been reported in patients with cirrhosis. Our objective was to determine whether anemia in cirrhotic patients is independently related to renal dysfunction. We conducted a retrospective chart review of patients in our institution listed for liver transplantation. We collected simultaneous data on age,hemoglobin, creatinine, albumin, liver enzymes, prothrombin time, and bilirubin. We excluded patients who were hospitalized or deceased to avoid confounding variables. Two hundred eighty-six (female n = 130) patients with a mean age of 52.8± 9.7(range,18-73) years were studied. Renal dysfunction(creatinine >1.2 mg/dL) was present in 55(19% ) patients, andanemia (hemoglobin<12 g/dL)was seen in 115 (40% ) patients.Anemia was more common in patients with renal dysfunction(64 versus 34% ;P< 0.001) compared to those with normal renal function. Creatinine, prothrombin time, and bilirubin showed an inverse relationship (all P s < 0.001) with hemoglobin, and albumin showed a positive correlation with hemoglobin (P < 0.001). Multivariate analysis showed that creatinine (OR, 2.4;95% CI, 1.05-5.3; P =0.038), prothrombin time (P=0.026),bilirubin (P=0.035), and albumin(P=0.001) were independent predictors of anemia. Renal dysfunction is an important cause of anemia in patients with cirrhosis. The role of erythropoietin in the management of anemia in patients with cirrhosis and renal dysfunction should be explored in prospective studies.
In patients with cirrhosis, anemia is common and is likely to be multifactorial, including decreased erythrocyte production,sequestration due to hypersplenism, hemolysis, and increased blood loss from gastrointestinal bleeding. Renal dysfunction is also common in liver disease and this may also cause anemia.However, an association between anemia and renal dysfunction has not been reported in patients with cirrhosis. Our objective was to determine whether anemia in cirrhotic patients is independently related to renal dysfunction. We conducted a retrospective chart review of patients in our institution listed for liver transplantation. We collected simultaneous data on age,hemoglobin, creatinine, albumin, liver enzymes, prothrombin time, and bilirubin. We excluded patients who were hospitalized or deceased to avoid confounding variables. Two hundred eighty-six (female n = 130) patients with a mean age of 52.8± 9.7(range,18-73) years were studied. Renal dysfunction(creatinine >1.2 mg/dL) was present in 55(19% ) patients, andanemia (hemoglobin<12 g/dL)was seen in 115 (40% ) patients.Anemia was more common in patients with renal dysfunction(64 versus 34% ;P< 0.001) compared to those with normal renal function. Creatinine, prothrombin time, and bilirubin showed an inverse relationship (all P s < 0.001) with hemoglobin, and albumin showed a positive correlation with hemoglobin (P < 0.001). Multivariate analysis showed that creatinine (OR, 2.4;95% CI, 1.05-5.3; P =0.038), prothrombin time (P=0.026),bilirubin (P=0.035), and albumin(P=0.001) were independent predictors of anemia. Renal dysfunction is an important cause of anemia in patients with cirrhosis. The role of erythropoietin in the management of anemia in patients with cirrhosis and renal dysfunction should be explored in prospective studies.
